Invention Grant
- Patent Title: Antibodies specific to IL-17A and IL-17F
- Patent Title (中): IL-17A和IL-17F特异性抗体
-
Application No.: US14173613Application Date: 2014-02-05
-
Publication No.: US09045537B2Publication Date: 2015-06-02
- Inventor: Thomas Allen Ceska , Alistar James Henry , Jiye Shi
- Applicant: UCB Pharma S.A.
- Applicant Address: BE Brussels
- Assignee: UCB PHARMA SA
- Current Assignee: UCB PHARMA SA
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB0807413.0 20080423
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; C07K14/54
Abstract:
The present invention relates neutralizing epitopes of IL-17A and IL-17F and antibodies which bind those epitopes. The present invention also relates to the therapeutic uses of the antibody molecules and methods for producing them.
Public/Granted literature
- US20140193403A1 Epitopes of IL-17A and IL-17F and Antibodies Specific Thereto Public/Granted day:2014-07-10
Information query
